Nimble Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.
BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US
Sasan Amini(Co-founder & CEO)Ramin Khaksar(Executive Officer)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)
PartnerJuan Scarlett· solo GP
Co-investorsMenlo VenturesKhosla VenturesDentsu VenturesFelicis VenturesNimble PartnersPrime Partners+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.